Literature DB >> 27104369

Empirical Combination Antibiotic Therapy Improves the Outcome of Nosocomial Meningitis or Ventriculitis in Neuro-Critical Care Unit Patients.

Zhiqi Li1, Xing Wu1, Jian Yu1, Xuehai Wu1, Zhuoying Du1, Yirui Sun1, Qiang Yuan1, Jin Hu1.   

Abstract

BACKGROUND: Nosocomial meningitis and ventriculitis (MEN) are serious complications in neuro-critical care unit (NCCU) patients. Few data are available on the risk factors and mortality rates among NCCU patients with these disorders caused by multi-drug-resistant (MDR) pathogens. Our aim was to identify the risk factors for MEN caused by such pathogens and in-hospital deaths in critically ill neurologic patients and to evaluate the impact of empirical combination antibiotic therapy (ECAT) on the outcomes of these patients.
METHODS: We conducted a retrospective study of critically ill neurologic patients having nosocomial MEN who were admitted to the NCCU in a university teaching hospital from January 2003 to December 2013, with MEN being defined using the modified U.S. Centers for Disease Control and Prevention criteria for nosocomial infections.
RESULTS: In total, 6,149 consecutive NCCU patients were screened; 132 had MEN. Logistic regression analysis demonstrated that MDR MEN was related to infection with gram-negative (GN) bacteria (odds ratio 3.16; 95% confidence interval [CI] 1.08-9.25; p = 0.036), and inadequate initial antibiotic therapy (odds ratio 9.80; 95% CI 3.79-25.32; p < 0.001). The ECAT was associated with a lower mortality rate (hazard ratio 0.35; 95% CI 0.14-0.86; p = 0.022) in Cox proportional hazard regression analysis. The other variable independently associated with a greater mortality rate was a greater Simplified Acute Physiology Score II (hazard ratio 1.07; 95% CI 1.01-1.13; p = 0.018).
CONCLUSIONS: Initial combination therapy improves the in-hospital mortality rate among NCCU patients with nosocomial MEN. Inadequate initial antibiotic therapy and GN infection were associated with MDR MEN.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27104369     DOI: 10.1089/sur.2015.060

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  4 in total

1.  Longitudinal Analysis of Risk Factors for Clinical Outcomes of Enterobacteriaceae Meningitis/Encephalitis in Post-Neurosurgical Patients: A Comparative Cohort Study During 2014-2019.

Authors:  Yi-Jun Shi; Guang-Hui Zheng; Ling-Ye Qian; Rasha Alsamani Qsman; Guo-Ge Li; Guo-Jun Zhang
Journal:  Infect Drug Resist       Date:  2020-07-06       Impact factor: 4.003

2.  Pyogenic Ventriculitis and Meningitis Caused by Streptococcus Acidominimus in Humans: A Case Report.

Authors:  Gaurang S Shah
Journal:  Am J Case Rep       Date:  2018-03-22

Review 3.  Current Perspectives on the Diagnosis and Management of Healthcare-Associated Ventriculitis and Meningitis.

Authors:  Marios Karvouniaris; Alexandros Brotis; Konstantinos Tsiakos; Eleni Palli; Despoina Koulenti
Journal:  Infect Drug Resist       Date:  2022-02-28       Impact factor: 4.003

4.  Population Pharmacokinetics and Dosing Regimen Optimization of Meropenem in Cerebrospinal Fluid and Plasma in Patients with Meningitis after Neurosurgery.

Authors:  Cheng Lu; Yuyi Zhang; Mingyu Chen; Ping Zhong; Yuancheng Chen; Jicheng Yu; Xiaojie Wu; Jufang Wu; Jing Zhang
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.